Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
OtherArticle

Screening and Identification of A Novel Anti-Siglec-15 Human Antibody 3F1 and Relevant Antitumor Activity

Jiaguo Wu, Jingyi Peng, Yangyihua Zhou, Ran Zhang, Zhihong Wang, Naijing Hu, Dingmu Zhang, Guiqi Quan, Yuanyu Wu, Jiannan Feng, Beifen Shen, Jian Zhao, Yan Zhang, Kaiming Yang and Longlong Luo
Molecular Pharmacology June 28, 2022, MOLPHARM-AR-2021-000470; DOI: https://doi.org/10.1124/molpharm.121.000470
Jiaguo Wu
1Dali University; Institute of Pharmacology and Toxicology, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: luolong_long@126.com
Jingyi Peng
2Institute of Pharmacology and Toxicology, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yangyihua Zhou
2Institute of Pharmacology and Toxicology, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ran Zhang
3Hunan Normal University School of Medicine, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhihong Wang
4State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naijing Hu
4State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dingmu Zhang
4State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guiqi Quan
2Institute of Pharmacology and Toxicology, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuanyu Wu
2Institute of Pharmacology and Toxicology, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiannan Feng
4State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beifen Shen
4State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Zhao
5JOINN Biologics, Co., LTD, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: luolong_long@126.com
Yan Zhang
6Department of Obstetrics and Gynecology, First Medical Center, General Hospital of Chinese PLA, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: luolong_long@126.com
Kaiming Yang
7School of Basic Medical Sciences of Dali University, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: luolong_long@126.com
Longlong Luo
2Institute of Pharmacology and Toxicology, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Longlong Luo
  • For correspondence: luolong_long@126.com
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Additional Files

  • Data Supplement

    • Supplemental Data -

      Supplementary Figure S1: The results of SEC-HPLC of 5 selected antibodies under natural conditions. Except for 1B4, which has the ability to form polymers, most of the other antibodies are in the form of monomers.

      Supplementary Figure S2: Fitting graph of association/dissociation of the three candidate antibodies. The KD values of each antibody were listed as showinthegraph.

      Supplementary Figure S3: Analysis of blocking activity between candidate antibodies and differentgands of Siglec-15.

      Supplementary Figure S4: Evaluation of the biological activity of candidate antibodies invitro.

      Supplementary Figure S5: The expression level of EGFR on the cell surface of H157(S15+).

      Supplementary Table S1 

Next
Back to top

In this issue

Molecular Pharmacology: 102 (3)
Molecular Pharmacology
Vol. 102, Issue 3
1 Sep 2022
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Screening and Identification of A Novel Anti-Siglec-15 Human Antibody 3F1 and Relevant Antitumor Activity
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherArticle

Human mAb 3F1 targeting the fuctional epitopes of Siglec-15

Jiaguo Wu, Jingyi Peng, Yangyihua Zhou, Ran Zhang, Zhihong Wang, Naijing Hu, Dingmu Zhang, Guiqi Quan, Yuanyu Wu, Jiannan Feng, Beifen Shen, Jian Zhao, Yan Zhang, Kaiming Yang and Longlong Luo
Molecular Pharmacology June 28, 2022, MOLPHARM-AR-2021-000470; DOI: https://doi.org/10.1124/molpharm.121.000470

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherArticle

Human mAb 3F1 targeting the fuctional epitopes of Siglec-15

Jiaguo Wu, Jingyi Peng, Yangyihua Zhou, Ran Zhang, Zhihong Wang, Naijing Hu, Dingmu Zhang, Guiqi Quan, Yuanyu Wu, Jiannan Feng, Beifen Shen, Jian Zhao, Yan Zhang, Kaiming Yang and Longlong Luo
Molecular Pharmacology June 28, 2022, MOLPHARM-AR-2021-000470; DOI: https://doi.org/10.1124/molpharm.121.000470
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The Regulation and Mechanisms of ImKTX58 on KV1.3 Channel
  • Effects of Small Molecule Ligands on ACKR3 Receptors
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics